MedPath
NMPA Approval

Ixazomib Citrate Capsules

国药准字HJ20180010

February 14, 2023

H20180010

Drug Information

枸橼酸伊沙佐米胶囊

恩莱瑞

胶囊剂

4mg(按C₁₄H₁₉BCl₂N₂O₄计 )

化学药品

February 14, 2023

February 13, 2028

Company Information

Applicant Company

Takeda Pharma A/S

Delta Park 45, 2665 Vallensbaek Strand, Denmark

Manufacturing Company

Donaustaufer Strasse 378, Regensburg, Bayern 93055, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

枸橼酸伊沙佐米胶囊 - NMPA 批准文号 | MedPath